Tectonic therapeutic to participate in september investor conferences

Watertown, mass., aug. 20, 2024 (globe newswire) -- tectonic therapeutic, inc. (nasdaq: tecx) (tectonic), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of g-protein coupled receptors (gpcrs), today announced that company management will present at the 2024 wells fargo healthcare conference being held in boston on september 4-6, 2024 and participate in the morgan stanley 22nd annual global healthcare conference being held in new york on september 4-6, 2024.
TECX Ratings Summary
TECX Quant Ranking